Evidence map›Paper›PMID 30352942›Full record

Observational studyThe oncologist2019

Phase Angle and the Diagnosis of Impending Death in Patients with Advanced Cancer: Preliminary Findings.

David Hui, Jessica Moore, Minjeong Park, Diane Liu, Eduardo Bruera

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in The oncologist, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Diagnostic and prognostic utility of phase angle in patients with cancer.Reviews in endocrine & metabolic disorders · 2023
    Review
  10. Article
  11. Association between PhA and Physical Performance Variables in Cancer Patients.International journal of environmental research and public health · 2023
    Article
  12. Article
  13. Article
  14. Prognostication of the Last Days of Life.Cancer research and treatment · 2022
    Article
  15. Article
  16. Observational
  17. Observational
  18. Prognostication in advanced cancer: update and directions for future research.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David HuiDepartment of Palliative Care, Rehabilitation and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas, USA dhui@mdanderson.org.
Jessica MooreSection of Integrated Ethics in Cancer Care, MD Anderson Cancer Center, Houston, Texas, USA.
Minjeong ParkDepartment of Biostatistics, MD Anderson Cancer Center, Houston, Texas, USA.
Diane LiuDepartment of Biostatistics, MD Anderson Cancer Center, Houston, Texas, USA.
Eduardo BrueraDepartment of Palliative Care, Rehabilitation and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer PatientsR01CA214960 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUI, DAVID · 2017 to 2020
$1.6M
Palliative Therapies for Refractory Delirium in Advanced CancerR21NR016736 · NINR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUI, DAVID · 2017 to 2018
$455k
Adjuvant Lorazepam for Agitated Delirium in the Palliative Care UnitR21CA186000 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUI, DAVID · 2015 to 2016
$399k
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA214960NCI NIH HHS R21 CA186000NINR NIH HHS R21 NR016736
6 · The paper itself

Abstract

backgroundPhase angle is a prognostic factor in patients with months of survival, but its accuracy has not been examined in patients with weeks/days of survival. We determined the association between phase angle and survival in patients with advanced cancer admitted to an acute palliative care unit (APCU). SUBJECTS, MATERIALS, AND

methodsWe prospectively assessed phase angle in consecutive patients with advanced cancer admitted to our APCU. We conducted univariate and multivariate survival analyses adjusting for established prognostic factors. Post hoc subgroup analyses examined patients with and without edema.

resultsAmong 204 patients, the median overall survival was 10 days (95% confidence interval [CI] 8-11 days). Seventy-four (36%) did not have edema. The median phase angle was 3.7° for the entire cohort, 3.9° for the nonedematous subgroup and 3.6° for the edematous subgroup. In univariate analysis, a low phase angle was associated with decreased survival for the entire cohort (≤3° vs. >3°, median survival 7 vs. 10 days,

conclusionPhase angle had limited prognostic utility in unselected APCU patients but was significant in the nonedematous subgroup. Further studies are required to confirm these preliminary findings. IMPLICATIONS FOR PRACTICE: In this prospective study involving 204 patients with advanced cancer, phase angle as measured by bioelectric impedance analysis was a significant predictor of mortality independent of known prognostic factors in patients without edema but not patients with edema. Among patients without edema, a phase angle ≤3° had an accuracy of 86% for 3-day survival, which may inform the diagnosis of impending death and potentially end-of-life decision making.

Indexed as

AdultAgedAged, 80 and overBody CompositionBody Mass IndexEdemaElectric ImpedanceFemaleHospitalizationHumansLongitudinal StudiesMaleMiddle AgedMultivariate AnalysisNeoplasmsNeoplasm StagingElectric impedanceForecastingNeoplasmsPalliative carePrognosisSurvival

Identifiers

PMID30352942
PMCPMC6656508
OpenAlexW2895947883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.